Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2 - PubMed (original) (raw)
Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2
F Taguchi. J Virol. 1993 Mar.
Abstract
The fusogenic properties of the uncleaved spike (S) protein of murine coronavirus JHMV variant cl-2 were studied by expressing the S protein with a deleted putative cleavage site. The amino acid sequence of the putative cleavage site, Arg-Arg-Ala-Arg-Arg, was replaced by Arg-Thr-Ala-Leu-Glu by in vitro mutagenesis of the cl-2 S protein cDNA. Recombinant vaccinia viruses containing the cl-2 S cDNA [RVV t(+)] or the mutated cDNA [RVV t(-)] were constructed and monitored for fusion formation and cleavage of the expressed S proteins. When cultured DBT cells were infected with RVV t(+) at a multiplicity of infection of 0.5, fusion formation was first observed at 10 to 12 h postinoculation and spread throughout the whole culture by 20 to 24 h postinoculation. In cells infected with RVV t(-) under the same conditions, fusion formation appeared by 12 to 14 h. This result represented a 2- to 4-h delay in the onset of fusion, compared with its appearance in cells expressing the wild-type S protein. By 25 to 30 h, most of the cells infected by RVV t(-) had fused. By immunoprecipitation and Western blotting (immunoblotting), the 170-kDa S protein was detected in DBT cells expressing the wild-type S protein and the mutated S protein. However, interestingly, the cleavage products of the S protein, S1 and S2, were not detected in RVV t(-)-infected cells, producing the mutated S protein, even though fusion was clearly visible. Both products were, of course, detected in RVV t(+)-infected DBT cells, producing the wild-type S protein. The same results concerning the fusion formation and cleavage properties of the S proteins were reproduced by the transiently expressed S proteins. These results suggest that the cleavage event in the S protein of murine coronavirus JHMV is not a prerequisite for fusion formation but that it does facilitate fusion formation.
Similar articles
- Fusogenic properties of uncleaved spike protein of murine coronavirus JHMV.
Taguchi F, Ikeda T, Saeki K, Kubo H, Kikuchi T. Taguchi F, et al. Adv Exp Med Biol. 1993;342:171-5. doi: 10.1007/978-1-4615-2996-5_27. Adv Exp Med Biol. 1993. PMID: 8209726 - Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2.
Taguchi F, Ikeda T, Shida H. Taguchi F, et al. J Gen Virol. 1992 May;73 ( Pt 5):1065-72. doi: 10.1099/0022-1317-73-5-1065. J Gen Virol. 1992. PMID: 1316938 - Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for its fusion activity.
Stauber R, Pfleiderer M, Siddell S. Stauber R, et al. Adv Exp Med Biol. 1993;342:165-70. doi: 10.1007/978-1-4615-2996-5_26. Adv Exp Med Biol. 1993. PMID: 8209724 - Site directed mutagenesis of the murine coronavirus spike protein. Effects on fusion.
Bos EC, Heijnen L, Spaan WJ. Bos EC, et al. Adv Exp Med Biol. 1995;380:283-6. doi: 10.1007/978-1-4615-1899-0_45. Adv Exp Med Biol. 1995. PMID: 8830493 Review. - Protease-dependent virus tropism and pathogenicity.
Nagai Y. Nagai Y. Trends Microbiol. 1993 Jun;1(3):81-7. doi: 10.1016/0966-842x(93)90112-5. Trends Microbiol. 1993. PMID: 8143121 Free PMC article. Review.
Cited by
- Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.
Qiu Z, Hingley ST, Simmons G, Yu C, Das Sarma J, Bates P, Weiss SR. Qiu Z, et al. J Virol. 2006 Jun;80(12):5768-76. doi: 10.1128/JVI.00442-06. J Virol. 2006. PMID: 16731916 Free PMC article. - Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor.
Matsuyama S, Taguchi F. Matsuyama S, et al. Virology. 2002 Mar 30;295(1):160-71. doi: 10.1006/viro.2002.1391. Virology. 2002. PMID: 12033774 Free PMC article. - Soluble receptor potentiates receptor-independent infection by murine coronavirus.
Taguchi F, Matsuyama S. Taguchi F, et al. J Virol. 2002 Feb;76(3):950-8. doi: 10.1128/jvi.76.3.950-958.2002. J Virol. 2002. PMID: 11773370 Free PMC article. - SARS--beginning to understand a new virus.
Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk HD, Rappuoli R. Stadler K, et al. Nat Rev Microbiol. 2003 Dec;1(3):209-18. doi: 10.1038/nrmicro775. Nat Rev Microbiol. 2003. PMID: 15035025 Free PMC article. Review. - The molecular biology of coronaviruses.
Masters PS. Masters PS. Adv Virus Res. 2006;66:193-292. doi: 10.1016/S0065-3527(06)66005-3. Adv Virus Res. 2006. PMID: 16877062 Free PMC article. Review.
References
- J Virol. 1985 Dec;56(3):904-11 - PubMed
- J Gen Virol. 1992 May;73 ( Pt 5):1065-72 - PubMed
- Virology. 1974 Feb;57(2):475-90 - PubMed
- Virology. 1981 Sep;113(2):503-11 - PubMed
- J Gen Virol. 1981 Mar;53(Pt 1):145-55 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources